AstraZeneca’s global consolidation drives data insights, savings and traveler satisfaction

U.K.-based biopharmaceutical giant AstraZeneca partnered with BCD Travel to bring 70 countries under global travel program management in just seven months. A case study explains how consolidation enabled innovations and improvements that led to results.

The company saved 15% on managed travel spend in one year. It gained data-centered, actionable insights into 95% of its managed travel spend. And the improved program performance helped the company achieve 86% traveler satisfaction.

“We needed comprehensive, consolidated data to understand where out-of-policy spend was happening and then make improvements,” said Kerrie Henshaw-Cox, AstraZeneca’s travel program leader. “Our consolidated travel program enables the travel team to better support AstraZeneca business leaders.”

Read more

Inform Report Managing air quality risk

What can corporate travel managers do to protect their travelers against air pollution? How can business travelers guard against the harmful effects of polluted air? This new Inform report about air quality and business travel helps travel managers to get informed about air pollution, find out if travelers are at risk and plan how to act on it.

Read more